Filters
Term Search
You can select from the dropdown list OR enter your own terms to refine the search.
Last Updated: 10/31/2025
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 520 publications
Cost-effectiveness of non-statin lipid-lowering therapies as an add-on to statins for achieving low-density lipoprotein cholesterol therapeutic targets in very high-risk patients in the Spanish setting.
Journal: Journal of medical economics
Published: October 20, 2025
Challenges in the Choice of Nonstatin Medications for Low-Density Lipoprotein-C Lowering for Cardiovascular Risk Reduction.
Journal: Journal of the American Heart Association
Published: October 09, 2025
Novel therapies for lowering low-density lipoprotein levels for atherosclerotic cardiovascular disease prevention: reaching the target where others have failed.
Journal: Expert review of cardiovascular therapy
Published: October 03, 2025
Inclisiran (Leqvio) monotherapy for LDL-cholesterol reduction.
Journal: The Medical letter on drugs and therapeutics
Published: September 09, 2025
Comment on: Real-World Efficacy of Inclisiran in Veneto Region (Italy)-Two-thirds at Target, What About the Others?
Journal: Cardiovascular drugs and therapy
Published: August 23, 2025
Inclisiran-based treatment strategy in hypercholesterolaemia: the VICTORION-Difference trial.
Journal: European heart journal
Published: July 30, 2025
Optimizing PCSK9 inhibitor therapy: Understanding and managing suboptimal LDL-C response in clinical practice.
Journal: European journal of internal medicine
Published: July 06, 2025
Real-World Efficacy of Inclisiran in Veneto Region (Italy): The INCLIVEN Multicenter Registry.
Journal: Cardiovascular drugs and therapy
Published: July 02, 2025
The Effects of Inclisiran on the Subclinical Prothrombotic and Platelet Activation Markers in Patients at High Cardiovascular Risk.
Journal: Journal of cardiovascular development and disease
Published: July 01, 2025
A Comprehensive Review of the Latest Approaches to Managing Hypercholesterolemia: A Comparative Analysis of Conventional and Novel Treatments: Part II.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: June 30, 2025
Comparative LDL-C Lowering Efficacy of Non-Statin Therapies: Inclisiran is Better than Ezetimibe, PCSK9 inhibitors, and Bempedoic Acid.
Journal: Journal of cardiovascular pharmacology
Published: June 25, 2025
Last Updated: 10/31/2025